Page last updated: 2024-11-04

sotalol and Chylopericardium

sotalol has been researched along with Chylopericardium in 2 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Research Excerpts

ExcerptRelevanceReference
"The pericardial effusion was interpreted as part of a postcardiotomy syndrome."1.30[Transitory left ventricular outflow tract obstruction after mitral valve reconstruction]. ( Hauber, J; Rein, JG; Sigel, H, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pasierb, MM1
Seslar, SP1
Hauber, J1
Rein, JG1
Sigel, H1

Other Studies

2 other studies available for sotalol and Chylopericardium

ArticleYear
Intravenous sotalol use in a complex critically ill child: balancing the systems in choosing antiarrhythmic medication.
    Cardiology in the young, 2017, Volume: 27, Issue:9

    Topics: Administration, Intravenous; Adolescent; Anti-Arrhythmia Agents; Bone Marrow Transplantation; Echoca

2017
[Transitory left ventricular outflow tract obstruction after mitral valve reconstruction].
    Deutsche medizinische Wochenschrift (1946), 1999, Sep-24, Volume: 124, Issue:38

    Topics: Adrenergic beta-Antagonists; Adult; Echocardiography; Follow-Up Studies; Heart Valve Prosthesis Impl

1999